Global Vaccine Market Expected to Reach $50.52 billion by 2023
The value of the vaccine market will reach $50.42 billion by 2023 from $36.45 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 6.7 percent, according to recently published report by private research firm MarketsandMarkets of India.1 The report provides an overview of the global vaccine market estimating the market size and potential for […]
CDC Accused of Manipulating Shingles Data
The varicella zoster (chickenpox) virus causes a generally mild and short-lived disease when it occurs in young children under age 12, as it almost always did prior to the live attenuated varicella vaccine being licensed in 1995 and recommended by the Centers for Disease Control and Prevention (CDC) for use by all children.1 Natural chickenpox […]
Goldman Sachs Exposes the Cure Dilemma
Story Highlights New gene therapies offer unprecedented hope for permanent cures of serious diseases and hold the promise of an invaluable societal impact. In a report to their biotech clients, investment giant Goldman Sachs questions whether curative therapies are a viable business model. Using Gilead Science’s hepatitis C drug as an example, the report noted […]
How NIH Uses U.S. Tax Dollars to Secure Profits for Vaccine Developers and Manufacturers
It is no secret that huge conflicts of interest exist between vaccine promoters and vaccine makers. Pediatrician and vaccine developer Paul Offit, for example, who is one of the nation’s leading promoters of mandatory use of government recommended vaccines, holds a $1.5 million research chair at Children’s Hospital in Philadelphia, funded in part by Merck.
Big Pharma Pays Universities for Most Medical Research in U.S. Today
In the past, collaboration between scientists in academia and pharmaceutical companies was relatively uncommon. However, lately there has been a growing interest in developing financial partnerships between these two sectors. The drug industry’s funding patterns for academic research has shifted from handpicked projects on investigation of…
Global Vaccines Market Worth $48 Billion by 2025
The global vaccines market is projected to reach $48 billion by 2025, according to new estimates detailed in a report from Transparency Market Research. The anticipated cumulative annual growth rate (CAGR) of six percent from 2017 to 2025, however, is lower than the research firm’s previous estimate. In 2016, Transparency Market…
